| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 12/17/2003 | EP1370668A2 Leporipox-based vector vaccines |
| 12/17/2003 | EP1370667A1 Avidin-pseudotyped viral vectors and their use |
| 12/17/2003 | EP1370666A2 Genetic immunisation against cervical carcinoma |
| 12/17/2003 | EP1370661A2 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy |
| 12/17/2003 | EP1370659A2 Proteins, polynucleotides encoding them and methods of using the same |
| 12/17/2003 | EP1370654A2 Chimpanzee erythropoietin (chepo) immunoadhesins |
| 12/17/2003 | EP1370586A2 Nuclear hormone receptor ligand binding domain |
| 12/17/2003 | EP1370584A2 Nuclear hormone receptor ligand binding domain |
| 12/17/2003 | EP1370580A2 A new essential downstream component of the wingless signalling pathway |
| 12/17/2003 | EP1370579A1 Matrix gene expression in chondrogenesis |
| 12/17/2003 | EP1370295A2 Neutral and anionic colloidal particles for gene delivery |
| 12/17/2003 | EP1370138A1 Gene therapy for neurological tissues |
| 12/17/2003 | EP1163024B1 Delivery of macromolecules into cells |
| 12/17/2003 | EP1007074B1 Hypothalamus-specific polypeptides |
| 12/17/2003 | EP0954580B1 Human sdf-5 protein and compositions |
| 12/17/2003 | EP0852490B1 Emulsion formulations for the delivery of nucleic acids to cells |
| 12/17/2003 | EP0571387B1 A non-mitogenic competitive hgf antagonist |
| 12/17/2003 | CN1462309A Codon-optimized papilloma virus sequences |
| 12/17/2003 | CN1462191A Treatment of ocute coronary syndrome with GLP-1 |
| 12/17/2003 | CN1461806A Human leukemia related reverse transcript virus gene genome nucleic acid sequence and its application |
| 12/17/2003 | CN1461753A H-type non virus carrier and medicinal compound containing same |
| 12/17/2003 | CN1131240C Chromosome 21 gene marker, compositions and methods using same |
| 12/17/2003 | CN1131208C Compound, their preparation and use for transferring nucleic acids into cells |
| 12/16/2003 | US6665563 System and method for enhancing cardiac signal sensing by cardiac pacemakers through genetic treatment |
| 12/16/2003 | US6664385 Kidney injury-related molecules |
| 12/16/2003 | US6664090 Carboxylesterase nucleic acid molecules, proteins and uses thereof |
| 12/16/2003 | US6664068 Antibodies, antiapoptotic agents |
| 12/16/2003 | US6664040 Complexing to polypeptides; antiproliferation agent |
| 12/16/2003 | US6663872 Immune response |
| 12/16/2003 | US6663868 Heat shock protein-based vaccines and immunotherapies |
| 12/16/2003 | US6663858 Antitumor, gene therapy |
| 12/16/2003 | US6663857 In vivo gene transfer using implanted retroviral producer cells |
| 12/16/2003 | US6663856 Gene therapy |
| 12/14/2003 | CA2432496A1 Diagnostic and therapeutic uses of sufu gene |
| 12/14/2003 | CA2430259A1 Vaccine |
| 12/11/2003 | WO2003103017A2 Method and system of determining chamber seasoning condition by optical emission |
| 12/11/2003 | WO2003102245A1 Antisense modulation of beta-site app-cleaving enzyme 2 expression |
| 12/11/2003 | WO2003102244A1 Antisense modulation of beta-site app-cleaving enzyme expression |
| 12/11/2003 | WO2003102237A1 Treatment with cytokines |
| 12/11/2003 | WO2003102230A1 Pthrp-based prediction and diagnosis of bone disease |
| 12/11/2003 | WO2003102214A2 Method for efficient rna interference in mammalian cells |
| 12/11/2003 | WO2003102206A2 Sgk and nedd used as diagnostic and therapeutic targets |
| 12/11/2003 | WO2003102191A1 Immunogenic sequences |
| 12/11/2003 | WO2003102186A1 Dna inducing cancer cell-specific expression and cancer cell-specific expression vector |
| 12/11/2003 | WO2003102185A2 Methods and compositions for treating neoplasia relating to hnrnp a1 and a2 nucleic acid molecules |
| 12/11/2003 | WO2003102183A1 Pramyxovirus vectors encoding antibody and utilization thereof |
| 12/11/2003 | WO2003102173A2 Protein or peptide (mimpd), nucleic acid that codes therefor, and uses of these substances |
| 12/11/2003 | WO2003102169A1 Anaerobe targeted enzyme-mediated prodrug therapy |
| 12/11/2003 | WO2003102163A2 Methods of diagnosing and treating diabetes and insulin resistance |
| 12/11/2003 | WO2003102151A2 Modulating cell differentiation and treating myeloprolifertive disorders with jnk/mkk inhibitors |
| 12/11/2003 | WO2003102147A2 Mutants of gad65 and ian5 relating to diabetes |
| 12/11/2003 | WO2003102140A2 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis |
| 12/11/2003 | WO2003102135A2 Control sequences of the human corin gene |
| 12/11/2003 | WO2003102131A2 Nucleic acid mediated disruption of hiv fusogenic peptide interactions |
| 12/11/2003 | WO2003102028A1 Rb1 gene induced protein (rb1cc1) and gene |
| 12/11/2003 | WO2003102023A1 Tumour-associated peptides that bond to mhc molecules |
| 12/11/2003 | WO2003102016A2 Amyloid peptide inactivating enzyme to treat alzheimer's disease |
| 12/11/2003 | WO2003102008A1 Antisense modulation of transcription factor dp-1 expression |
| 12/11/2003 | WO2003101494A1 Materials and methods relating to polyions and substance delivery |
| 12/11/2003 | WO2003101396A2 Helper virus-free herpesvirus amplicon particles and uses thereof |
| 12/11/2003 | WO2003101394A2 Defensins: use as antiviral agents |
| 12/11/2003 | WO2003101386A2 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis |
| 12/11/2003 | WO2003101202A1 Intraperitoneal delivery of genetically engineered mesenchymal stem cells |
| 12/11/2003 | WO2003101201A1 Intramyocardial injection of autologous bone marrow |
| 12/11/2003 | WO2003078597A9 Tissue engineering |
| 12/11/2003 | WO2003074685A3 Il-10 gene transfer to peripheral blood mononuclear cells |
| 12/11/2003 | WO2003054212A3 A method and compositions for conferring viral immunity and reversing viral pathogenesis via strategic infection with a theravirus thereby providing genomic integration of genetically engineered, replication incompetent, integrating viral dna |
| 12/11/2003 | WO2003051834A3 Immunocellular receptors related to neurological disorders |
| 12/11/2003 | WO2003051180A3 METHODS AND COMPOSITIONS FOR TREATING HEMATOLOGICAL DISORDERS USING 252, 304, 19870, 14717, 9941, 19310 and 17832 |
| 12/11/2003 | WO2003038037A3 Glycogen synthase kinase function in endothelial cells |
| 12/11/2003 | WO2003037172A9 Endothelial-cell binding peptides for diagnosis and therapy |
| 12/11/2003 | WO2003037166A3 Devices and methods for the restoration of a spinal disc |
| 12/11/2003 | WO2003029486A3 Single nucleotide polymorphisms predicting cardiovascular disease |
| 12/11/2003 | WO2003029407A3 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 12/11/2003 | WO2003026579A3 Combination therapies for immune mediated diseases |
| 12/11/2003 | WO2003017940A3 Pulsatile release compositions and methods for enhanced gastrointestinal drug absorption |
| 12/11/2003 | WO2003002745A3 The cage gene of actinobacillus actinomycetemcomitans, the protein it encodes and uses thereof |
| 12/11/2003 | WO2003000727A3 Atopy |
| 12/11/2003 | WO2002077034A3 Modified granulocyte colony stimulating factor (g-csf) with reduced immunogenicity |
| 12/11/2003 | WO2002072013A3 Method of treating malignancies through induction of blood immune responses |
| 12/11/2003 | WO2002064788A3 Compositions and methods relating to lung specific genes and proteins |
| 12/11/2003 | WO2002060928A3 Medane genes and proteins |
| 12/11/2003 | US20030229911 Compositions and methods for wound healing |
| 12/11/2003 | US20030229910 Preparing transgenic cattle which are resistant to bovine spongioform encephalopathy; homologous recombination; animal husbandry; veterinary medicine |
| 12/11/2003 | US20030229904 Comprises polypeptide for diagnosis, treatment and prevention of tumors |
| 12/11/2003 | US20030229903 Novel system for the evaluation of the activity and/or specificity of a viral component |
| 12/11/2003 | US20030229220 Oligomer phosphoramidite compositions and processes for synthesizing the same |
| 12/11/2003 | US20030229217 Comprises gamma-amino butyric acid (GABA) receptor subunits for treatment of obesity, vision defects, high blood pressure, depression and sexual disorders |
| 12/11/2003 | US20030229209 Comprises mitogen-activated protein (MAP) kinase polypeptide for treating muscular, diabetic and nervous system disorders |
| 12/11/2003 | US20030229204 PCG-1, a novel brown fat PPARgamma coactivator |
| 12/11/2003 | US20030229065 Measuring drug resistance, calibration; reducing antibiotic resistance |
| 12/11/2003 | US20030229053 Compounds and methods for the treatment or prevention of flavivirus infections |
| 12/11/2003 | US20030229046 Genetic engineering; polynucleotides; translation of codon of human cytomegalo virus |
| 12/11/2003 | US20030229045 CFTR gene regulator |
| 12/11/2003 | US20030229043 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 12/11/2003 | US20030229042 Methods and compositions for therapies using genes encoding secreted proteins |
| 12/11/2003 | US20030229041 Administering steroid compound |
| 12/11/2003 | US20030229039 Gene therapy; mutant Dna |
| 12/11/2003 | US20030229036 Administering Dna vector; genetic engineering; gene replacement therapy |
| 12/11/2003 | US20030229035 Method of restoring ciliated cell motility |